down arrow

Consun Pharmaceutical Group Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG2524A1031
HKD
14.87
-0.13 (-0.87%)

Dec 12

HKG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Dec'17
Net Sales
2,862.07
2,720.73
2,464.25
1,969.64
1,959.70
2,184.10
1,914.39
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,862.07
2,720.73
2,464.25
1,969.64
1,959.70
2,184.10
1,914.39
Raw Material Cost
738.62
670.68
623.48
484.49
529.37
544.31
497.94
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
534.28
518.26
441.10
319.06
345.56
340.48
406.37
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
23.50
12.71
15.55
24.05
32.93
32.54
17.01
Selling and Distribution Expenses
1,156.57
1,098.26
939.82
777.26
788.82
793.73
759.53
Other Expenses
-43.78
-39.43
-33.35
-24.91
-29.30
-29.26
-37.14
Total Expenditure (Excl Depreciation)
2,015.13
1,905.62
1,686.43
1,355.76
1,403.66
1,418.52
1,309.44
Operating Profit (PBDIT) excl Other Income
846.9
815.1
777.8
613.9
556
765.6
604.9
Other Income
130.94
65.57
76.39
66.10
-1.73
-2.60
40.48
Operating Profit (PBDIT)
1,063.63
968.90
941.58
760.07
636.59
843.18
718.47
Interest
23.50
12.71
15.55
24.05
32.93
32.54
17.01
Exceptional Items
0.00
0.00
0.00
0.00
-369.81
0.00
0.00
Gross Profit (PBDT)
2,123.45
2,050.05
1,840.76
1,485.15
1,430.33
1,639.79
1,416.45
Depreciation
85.74
88.22
87.36
80.08
82.28
80.20
73.05
Profit Before Tax
954.39
867.96
838.66
655.94
151.56
730.45
628.41
Tax
85.25
72.91
131.06
114.61
79.99
141.20
142.02
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
866.91
794.14
711.28
560.48
90.51
551.19
456.90
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
866.91
794.14
711.28
560.48
90.51
551.19
456.90
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
2.23
0.92
-3.68
-19.15
-18.93
38.07
29.49
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
869.14
795.06
707.60
541.33
71.58
589.26
486.40
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
3,992.80
3,531.17
3,202.15
2,632.56
2,230.57
2,460.00
2,096.80
Earnings per share (EPS)
1.08
1.0
0.88
0.69
0.11
0.63
0.53
Diluted Earnings per share
1.08
1.0
0.88
0.69
0.11
0.63
0.53
Operating Profit Margin (Excl OI)
29.59%
29.96%
31.56%
31.17%
28.37%
35.05%
31.6%
Gross Profit Margin
36.34%
35.14%
37.58%
37.37%
11.93%
37.12%
36.64%
PAT Margin
30.29%
29.19%
28.86%
28.46%
4.62%
25.24%
23.87%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2023 is 5.20% vs 10.41% in Dec 2022

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2023 is 9.31% vs 12.37% in Dec 2022

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2023 is 3.25% vs 4.40% in Dec 2022

stock-summary

Interest

YoY Growth in year ended Dec 2023 is 85.04% vs -18.59% in Dec 2022

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2023 has fallen from Dec 2022

Compare Annual Results Of Consun Pharmaceutical Group Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
2,862.07
6,955.50
-4,093.43
-58.85%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,862.07
6,955.50
-4,093.43
-58.85%
Raw Material Cost
738.62
1,446.24
-707.62
-48.93%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
534.28
881.17
-346.89
-39.37%
Power Cost
0
0
0.00
Manufacturing Expenses
23.50
251.27
-227.77
-90.65%
Selling and Distribution Expenses
1,156.57
2,143.12
-986.55
-46.03%
Other Expenses
-43.78
-92.00
48.22
52.41%
Total Expenditure (Excl Depreciation)
2,015.13
3,801.84
-1,786.71
-47.00%
Operating Profit (PBDIT) excl Other Income
846.95
3,153.66
-2,306.71
-73.14%
Other Income
130.94
48.02
82.92
172.68%
Operating Profit (PBDIT)
1,063.63
3,634.97
-2,571.34
-70.74%
Interest
23.50
251.27
-227.77
-90.65%
Exceptional Items
0.00
-600.30
600.30
100.00%
Gross Profit (PBDT)
2,123.45
5,509.26
-3,385.81
-61.46%
Depreciation
85.74
433.29
-347.55
-80.21%
Profit Before Tax
954.39
2,350.11
-1,395.72
-59.39%
Tax
85.25
299.39
-214.14
-71.53%
Provisions and contingencies
0
0
0.00
Profit After Tax
866.91
2,201.85
-1,334.94
-60.63%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
866.91
2,201.85
-1,334.94
-60.63%
Share in Profit of Associates
0
0
0.00
Minority Interest
2.23
-151.16
153.39
101.48%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
869.14
2,050.68
-1,181.54
-57.62%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
3,992.80
8,737.04
-4,744.24
-54.30%
Earnings per share (EPS)
1.08
2.50
-1.42
-56.80%
Diluted Earnings per share
1.08
2.50
-1.42
-56.80%
Operating Profit Margin (Excl OI)
29.59%
45.34%
0.00
-15.75%
Gross Profit Margin
36.34%
40.02%
0.00
-3.68%
PAT Margin
30.29%
31.66%
0.00
-1.37%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 286.21 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 5.20% vs 10.41% in Dec 2022

Annual - Consolidate Net Profit
Consolidate Net Profit 86.91 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 9.31% vs 12.37% in Dec 2022

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 93.27 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 3.25% vs 4.40% in Dec 2022

Annual - Interest
Interest 2.35 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 85.04% vs -18.59% in Dec 2022

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 29.59%
in Dec 2023

Figures in %
stock-summary

YoY Growth in year ended Dec 2023 has fallen from Dec 2022

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."